MSF representatives will speak at the 154th session of the WHO Executive Board (EB) on a number of topics.

On World Diabetes Day, we showcase the benefits of insulin pens for people living with diabetes

A discussion during WHA 2023 on pandemic preparedness and response, with access to Ebola treatments as an example

MSF activities at the 76th session of the World Health Assembly (WHA), 21-30 May 2023.

MSF representatives will speak at the 152nd session of the WHO Executive Board (EB) on a number of topics.

MSF activities at the 75th session of the World Health Assembly (WHA), 22-28 May 2022.

How can disclosing clinical trial costs increase access to medical products?

MSF, as a registered non-State actor with the WHO, expresses our strong concerns on the proposal put forward to supposedly improve NSA’s role, voice and contribution in WHO’s governing system.

MSF welcomes the report " Global strategy and plan of action on public health, innovation and intellectual property, for the period 2008-2022" and supports the extension of the plan of action on public health, innovation and IP until ...

MSF activities at the 74th session of the World Health Assembly (WHA), 24 May to 1 June 2021.

MSF representatives are participating in the 148th session of the WHO executive board meetings and will be speaking on a number of topics. Click here to watch the livestream and read our statements below.

The World Health Assembly (WHA), the annual meeting of the world’s health ministers, is taking place virtually for the first time on 18 May 2020. MSF briefing document on agenda item: COVID-19 response Position paper on the sharing of ...

MSF representatives are attending the 146th session of the WHO executive board meetings and will be speaking on a number of topics.